4//SEC Filing
Ramasastry Saira 4
Accession 0001415889-25-024128
CIK 0001759425other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 5:50 PM ET
Size
8.6 KB
Accession
0001415889-25-024128
Insider Transaction Report
Form 4
Ramasastry Saira
Director
Transactions
- Exercise/Conversion
Common Stock
2025-09-08$23.51/sh+17,000$399,670→ 17,000 total - Sale
Common Stock
2025-09-08−17,000→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2025-09-08−17,000→ 17,000 totalExercise: $23.51Exp: 2032-06-01→ Common Stock (17,000 underlying)
Footnotes (2)
- [F1]The weighted average sale price for the transaction reported was $77.042178, and the range of prices were between $76.835 and $77.29. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F2]The stock option is fully vested.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001547959
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 5:50 PM ET
- Size
- 8.6 KB